SURMONTIL

This brand name is authorized in Finland, France, Hong Kong SAR China, Ireland, Japan, Spain, Tunisia.

Active ingredients

The drug SURMONTIL contains one active pharmaceutical ingredient (API):

1	Trimipramine UNII 269K6498LD - TRIMIPRAMINE MALEATE
	Trimiparamine is a tricyclic antidepressant. It has marked sedative properties. It is, therefore, indicated in the treatment of depressive illness, especially where sleep disturbance, anxiety or agitation are presenting symptoms.

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SURMONTIL Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AA06	Trimipramine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AA Non-selective monoamine reuptake inhibitors
Discover more medicines within N06AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	40115
FI	Lääkealan turvallisuus- ja kehittämiskeskus	436535
FR	Base de données publique des médicaments	63344192, 63905138, 64868034
HK	Department of Health Drug Office	31113
IE	Health Products Regulatory Authority	46108, 47651
JP	医薬品医療機器総合機構	1174005B1020, 1174005F1022, 1174005F2029
TN	Direction de la Pharmacie et du Médicament	6390211, 6390212